Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLeg cramps are reported by some people taking Mounjaro, and while they are not listed as a common side effect in the official prescribing information, there is a plausible physiological reason why they happen. Dehydration and electrolyte shifts — both of which can follow the nausea, vomiting or reduced food intake that tirzepatide sometimes brings — are well-recognised triggers for muscle cramps. This page covers what the evidence says, what you can do, and when cramping is worth raising with your prescriber. Mounjaro is a prescription-only medicine, so anything specific to your situation should go through a clinician rather than a search engine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro Summary of Product Characteristics, published on the electronic Medicines Compendium, does not list leg cramps among the common or very common adverse effects. That matters, because it tells us cramps are not a direct pharmacological effect of tirzepatide on muscle tissue. What the SmPC does record prominently is a GI-led side-effect profile: nausea, vomiting, diarrhoea and reduced appetite are all common, particularly in the early weeks or after each dose step up.
This is where the link to leg cramps comes in. Fluid losses from vomiting or diarrhoea, combined with eating far less than usual, can deplete the electrolytes your muscles depend on, magnesium and potassium most notably. Both deficiencies are associated with nocturnal and exertional muscle cramps in the general medical literature, and you can read more about how Mounjaro relates to cramps more broadly. The NHS patient information on tirzepatide notes dehydration as a risk to monitor, and the same NHS England guidance that covers weight-management injections highlights the importance of adequate fluid and nutrient intake alongside treatment.
A misconception worth setting aside gently: some people assume the injection site is responsible, believing the medicine is somehow irritating the leg muscle itself. Mounjaro is injected subcutaneously in the abdomen, thigh or upper arm, and the active medicine acts on gut-hormone receptors, not directly on peripheral muscle. If you are wondering whether Mounjaro is causing stomach cramps as well as leg cramps, those two experiences often share the same underlying mechanisms. Cramps in the legs are almost certainly downstream of the systemic effects described above, not a local reaction.
The most consistently useful starting point is hydration. Aiming for around 2–2.5 litres of fluid a day is a reasonable general target, though your own needs depend on body size, activity and how active your GI side effects are. Plain water, diluted squash and broth all count. Caffeine and alcohol are mildly dehydrating, so keeping those moderate during the adjustment phase makes sense.
Diet quality matters too. When appetite falls sharply on tirzepatide, it is easy to eat too little of the foods that supply magnesium (leafy greens, nuts, seeds, wholegrains) and potassium (bananas, potatoes, lentils, fish). Eating less overall is the point of treatment, but eating nutrient-poor meals is not. The Mounjaro must-haves guide covers practical food choices that support the medicine's effects without compounding deficiencies.
Gentle stretching of the calf and foot muscles before bed is a non-pharmacological approach with reasonable evidence behind it in the general cramp literature. Keeping bed covers loose so feet are not plantar-flexed for hours is another low-effort adjustment.
If cramps are frequent and disruptive, your prescriber may consider checking serum electrolytes and, if levels are low, discuss supplementation. This is a clinical decision, supplementing magnesium or potassium without knowing your baseline can cause its own problems, so it is worth raising through your normal aftercare route rather than self-prescribing.
Occasional, brief muscle cramps that resolve on their own are uncomfortable but not a red flag. The picture changes if cramps are severe and last more than a few minutes, happen repeatedly despite good hydration, or come alongside other symptoms such as leg swelling, redness, warmth or localised pain that persists after the cramp has passed. Those features need prompt clinical review because they could point to something unrelated to tirzepatide altogether, including a deep vein thrombosis.
Persistent vomiting or diarrhoea that makes it impossible to keep fluids down is also a reason to seek medical help, not just because of the cramp risk, but because the MHRA Drug Safety Update on GLP-1 medicines flags dehydration and kidney strain as serious concerns when GI symptoms are severe. If you are a nume patient and have questions about cramping during your course of treatment, the priority aftercare line is available seven days a week, reach the team through our contact page.
It helps to understand leg cramps within the broader side-effect picture rather than in isolation. Tirzepatide is a dual GIP and GLP-1 receptor agonist, the only medicine of its kind licensed in the UK for weight management. Its clinical trial programme involved thousands of adults across the SURMOUNT studies, and the safety data from that programme are now well characterised. GI symptoms dominate the early-treatment period, particularly nausea; most people find they settle within one to two weeks of starting a new dose.
The stomach cramping page covers the abdominal side of that picture in more depth, and for those who want to understand the specific question of whether Mounjaro affects period cramps, that is covered separately. The broader Mounjaro overview sets out how the medicine works and what the licence covers. If you are considering starting treatment and want to understand the full side-effect and eligibility picture, reading through both is a good preparation before speaking to a prescriber. Understanding what is and is not caused by the medicine is part of getting the most from it safely. For a sense of the treatment landscape and pricing, the weight-loss treatments overview gives a clear starting point.
Mounjaro requires a prescription following a clinical assessment, a prescriber reviews your full medical picture before treatment is approved. If you are ready to find out whether it is suitable for you, check your eligibility with a free consultation and a named prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.